Tomorrow, @myESMO Congress 2026 opens its doors in Madrid. And the first-in-human Phase I clinical trial of RS-0139 is part of the scientific programme (1095eP). A poster tells part of the story. The rest happens in conversation. See you at #ESMO2026 w/ @gulsahnomak11